Coxiella burnetii Phase I protein antigens (C. burnetii Phase I antigens)

Coxiella burnetii Phase I protein antigens are a group of proteins expressed by the virulent, highly infectious form of the bacterium responsible for Q fever [1]. Unlike the avirulent Phase II form, Phase I C. burnetii possesses a complete lipopolysaccharide (LPS) structure that shields these surface proteins from early immune recognition, contributing to its pathogenicity [3]. These antigens are critical targets for vaccine development, as they are necessary to elicit a protective immune response that mimics natural exposure to the wild-type organism [4]. The only commercially available vaccine, Q-Vax, utilizes whole-cell inactivated Phase I organisms, though research into specific recombinant protein subunits (such as Com1 or OmpA) is ongoing to reduce side effects [3]. A significant challenge in targeting these antigens is the risk of severe hypersensitivity reactions in individuals with prior exposure, necessitating rigorous pre-vaccination screening [4]. These antigens play a vital role in the intracellular survival of the pathogen within host macrophages [2].

Other names

Q fever Phase I antigensCoxiella burnetii virulent phase antigensPhase I C. burnetii proteinsCoxiella burnetii whole-cell antigens

Induction of protective immunity through the activation of T-cell mediated and humoral immune responses against virulent Phase I Coxiella burnetii [3][4]